Fulgent Genetics, Inc. (FLGT) insider trading.
In Q3 2026, insiders at Fulgent Genetics, Inc. reported 11 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $117K.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 4
- Net shares, P minus S
- -5,932
- Insiders
- 4
- Last filed
- 2026-09-03
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Gao Hanlin | Officer · Chief Scientific Officer | 3 | 0 | 2 |
| Xie Jian | Officer · President and COO | 3 | 0 | 2 |
| Kim Paul | Officer · CFO and Treasurer | 3 | 0 | 0 |
| Hsieh Ming | Director, Officer, TenPercentOwner · Chief Executive Officer | 2 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Gao Hanlin | S (D) | 1,673 | $19.66 | 986,117 | Form 4 |
| 2026-09-02 | Xie Jian | S (D) | 2,127 | $19.66 | 359,924 | Form 4 |
| 2026-09-01 | Kim Paul | F (D) | 2,087 | $19.59 | 356,543 | Form 4 |
| 2026-09-01 | Hsieh Ming | F (D) | 4,392 | $19.59 | 885,952 | Form 4 |
| 2026-08-27 | Gao Hanlin | S (D) | 939 | $19.91 | 987,790 | Form 4 |
| 2026-08-27 | Xie Jian | S (D) | 1,193 | $19.91 | 362,051 | Form 4 |
| 2026-08-26 | Kim Paul | F (D) | 1,168 | $19.81 | 358,630 | Form 4 |
| 2026-08-26 | Hsieh Ming | F (D) | 2,949 | $19.81 | 890,344 | Form 4 |
| 2026-07-26 | Gao Hanlin | F (D) | 1,645 | $19.67 | 988,729 | Form 4 |
| 2026-07-26 | Xie Jian | F (D) | 4,361 | $19.67 | 363,244 | Form 4 |
| 2026-07-26 | Kim Paul | F (D) | 2,747 | $19.67 | 359,798 | Form 4 |
Transaction codes in this quarter
Get FLGT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1674930&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · FLGT company page · Fulgent Genetics, Inc. on SEC.gov
Questions
Are insiders buying or selling Fulgent Genetics, Inc. (FLGT)?
In Q3 2026, insiders at Fulgent Genetics, Inc. reported 11 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $117K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Fulgent Genetics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/flgt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.